Pictet Asset Management Holding SA Decreases Stake in Ingevity Corporation $NGVT

Pictet Asset Management Holding SA lowered its position in shares of Ingevity Corporation (NYSE:NGVTFree Report) by 16.0% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 301,903 shares of the company’s stock after selling 57,307 shares during the quarter. Pictet Asset Management Holding SA owned 0.86% of Ingevity worth $21,505,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Louisiana State Employees Retirement System purchased a new stake in shares of Ingevity during the first quarter valued at approximately $1,133,000. Contravisory Investment Management Inc. bought a new position in Ingevity in the 1st quarter valued at $278,000. RFG Advisory LLC purchased a new stake in shares of Ingevity during the 1st quarter valued at $279,000. SG Americas Securities LLC increased its position in shares of Ingevity by 115.8% during the 1st quarter. SG Americas Securities LLC now owns 18,595 shares of the company’s stock valued at $1,325,000 after purchasing an additional 9,980 shares during the last quarter. Finally, Evolve Private Wealth LLC raised its stake in shares of Ingevity by 10.2% during the 1st quarter. Evolve Private Wealth LLC now owns 5,946 shares of the company’s stock worth $424,000 after purchasing an additional 549 shares during the period. Hedge funds and other institutional investors own 91.59% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on NGVT shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a report on Tuesday, April 21st. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Monday. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $80.00.

Read Our Latest Stock Analysis on NGVT

Ingevity Stock Performance

Shares of NGVT opened at $72.72 on Thursday. Ingevity Corporation has a 1 year low of $39.74 and a 1 year high of $79.29. The company has a debt-to-equity ratio of 27.83, a current ratio of 1.42 and a quick ratio of 0.92. The stock’s fifty day moving average price is $71.32 and its two-hundred day moving average price is $68.99. The firm has a market cap of $2.53 billion, a PE ratio of -20.48 and a beta of 1.16.

Ingevity (NYSE:NGVTGet Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.31. Ingevity had a positive return on equity of 207.82% and a negative net margin of 10.55%.The company had revenue of $258.00 million during the quarter, compared to the consensus estimate of $254.73 million. During the same quarter in the prior year, the company earned $1.01 EPS. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, equities research analysts forecast that Ingevity Corporation will post 5.05 EPS for the current year.

Insiders Place Their Bets

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $68.49, for a total transaction of $33,971.04. Following the completion of the transaction, the senior vice president owned 7,202 shares in the company, valued at $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.88% of the stock is owned by corporate insiders.

Ingevity Company Profile

(Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Recommended Stories

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corporation (NYSE:NGVTFree Report).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.